Lexeo Therapeutics, Inc. Common Stock Long-term Investment Intensity
Lexeo Therapeutics, Inc. Common Stock long-term investment intensity. Lexeo Therapeutics, Inc. Common Stock (LXEO) has a Long-term Investment Intensity of 10.1% as of June 2026. Long-term investments of $25.86 Million represent 10.1% of total assets of $254.90 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read debt load of Lexeo Therapeutics, Inc. Common Stock for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Lexeo Therapeutics, Inc. Common Stock (2024–2025)
Long-term investment intensity of Lexeo Therapeutics, Inc. Common Stock from 2024 to 2025. This chart shows how Lexeo Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the intensity stands at 10.1%, reflecting long-term investments of $25.86 Million against total assets of $254.90 Million USD.
Lexeo Therapeutics, Inc. Common Stock Long-term Investment Intensity by Year (2024–2025)
Lexeo Therapeutics, Inc. Common Stock long-term investment intensity by year from 2024 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Lexeo Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see LXEO asset base.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 25.4% | $68.19 Million | $268.69 Million | ▲ +20.6 pp |
| 2024 | 4.8% | $7.01 Million | $146.94 Million | — |